Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | USP2 | O75604 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.31 |
| ▸ | SPHK2 | Q9NRA0 | 2/20 | 0.30 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.30 |
| ▸ | CETP | P11597 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3116802 | 0.98 | TSHR (0.46) | TSHRALDH1A1MAPTUSP2CYP3A4 | |
| SCHEMBL29076804 | 0.92 | TSHR (0.61) | TSHRALDH1A1MAPTUSP2CYP3A4 | |
| SCHEMBL876350 | 0.92 | TSHR (0.61) | TSHRALDH1A1MAPTUSP2CYP3A4 | |
| SCHEMBL3107961 | 0.86 | TSHR (0.46) | TSHRALDH1A1MAPTUSP2CYP3A4 | |
| SCHEMBL19895218 | 0.86 | TSHR (0.53) | TSHRALDH1A1SPHK2SPHK1CETP | |
| SCHEMBL13772820 | 0.84 | TSHR (0.42) | TSHRALDH1A1 | |
| SCHEMBL28977214 | 0.83 | TSHR (0.50) | TSHRALDH1A1CYP3A4HPGDLMNA | |
| SCHEMBL30274160 | 0.83 | TSHR (0.50) | TSHRALDH1A1CYP3A4HPGDLMNA | |
| SCHEMBL28977210 | 0.83 | TSHR (0.50) | TSHRALDH1A1CYP3A4HPGDLMNA | |
| SCHEMBL30274164 | 0.83 | TSHR (0.50) | TSHRALDH1A1CYP3A4HPGDLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3327125-A1 | RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACIDS (SINA) | Sirna Therapeutics, Inc. (US) | 2018-05-30 | — | — | EP | disclosed |